Canadian Specialists Advocate for Action to Eliminate Cervical Cancer by 2040

Canadian health specialists have set forth a strategy to eliminate cervical cancer by 2040, focusing on increased HPV vaccination and primary HPV screening. Despite progress, challenges like uneven vaccination rates across provinces and rising cancer incidence persist.

CANOPTICON·

In a significant stride towards public health, Canadian health specialists have outlined a comprehensive plan to eliminate cervical cancer as a public health problem by 2040. The recommendations emerged from a recent presentation which emphasized the critical role of HPV vaccination and primary HPV screening in achieving this ambitious goal.

cervical cancer awareness in Canada

Key Recommendations

Vaccination: To meet targets, specialists advocate achieving a 90% HPV vaccination uptake among children under 18 by 2025. The current rates are insufficient, leading to urgent calls for federal action to boost vaccination coverages, such as extending age thresholds for free vaccination in areas like British Columbia and Alberta.

HPV vaccines are known to prevent over 90% of cervical cancers, yet disparities in vaccination rates across provinces pose a challenge.

Screening: The shift to primary HPV screening is advised for all provinces and territories by 2035. Newly proposed guidelines recommend regular screening for individuals with a cervix between the ages of 25 and 69. HPV tests, conducted every five years, are preferred over the traditional Pap tests for their accuracy in detecting high-risk strains of HPV.

The adoption of HPV self-collection tests, which could enhance equity and access, particularly for underserved communities, is also recommended.

Current Challenges

Despite advances in prevention technologies, cervical cancer remains the fastest-growing cancer in Canada, with the incidence exceeding 4 cases per 100,000, compared to the elimination threshold of fewer than 4. In 2025 alone, there were nearly 430 cervical cancer-related deaths.

Advocates, including the Society of Gynecologic Oncology and the Women's Health Coalition, have highlighted the necessity of standardized, nationwide screening protocols and the elimination of care disparities, particularly in marginalized communities such as Indigenous populations.

These organizations stress that maintaining strong vaccination efforts and national HPV screening programs by 2030 are crucial to the elimination efforts projected for 2040.

For individual guidance, Canadians are advised to consult provincial guidelines and healthcare providers, as specific recommendations may vary.

Photo by Milad Fakurian on Unsplash